These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17010443)

  • 21. 5-HT7 receptor antagonists as a new class of antidepressants.
    Mnie-Filali O; Lambás-Señas L; Zimmer L; Haddjeri N
    Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-monoaminergic targets for the development of antidepressants: focus on neuropeptides.
    Catena-Dell'Osso M; Fagiolini A; Marazziti D; Baroni S; Bellantuono C
    Mini Rev Med Chem; 2013 Jan; 13(1):2-10. PubMed ID: 22876945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview.
    Berlim MT; Fleck MP; Turecki G
    Ann Med; 2008; 40(2):149-59. PubMed ID: 18293145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of neurobiologic processes in treating depression.
    Thase ME
    J Clin Psychiatry; 2010 Oct; 71(10):e28. PubMed ID: 21062614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental methods for evaluation of psychotropic agents in rodents: II-Antidepressants.
    Bhattacharya SK; Satyan KS; Ramanathan M
    Indian J Exp Biol; 1999 Feb; 37(2):117-23. PubMed ID: 10641129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of glutamate receptors: strategies for the development of novel antidepressants.
    Skolnick P
    Amino Acids; 2002; 23(1-3):153-9. PubMed ID: 12373530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging drugs for major depressive disorder.
    Kennedy SH; Rizvi SJ
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The approaches in the discovery of antidepressants using affective disorder models].
    Saitoh A; Yamaguchi K; Murasawa H; Kamei J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):75-82. PubMed ID: 12762219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight gain with antidepressants and lithium.
    Garland EJ; Remick RA; Zis AP
    J Clin Psychopharmacol; 1988 Oct; 8(5):323-30. PubMed ID: 3053797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palliative care and HIV, part II: systemic manifestations and late-stage issues.
    Reiter GS; Kudler NR
    AIDS Clin Care; 1996 Apr; 8(4):27-30, 33, 36. PubMed ID: 11363257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities.
    Baghai TC; Volz HP; Möller HJ
    World J Biol Psychiatry; 2006; 7(4):198-222. PubMed ID: 17071541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A practical approach to prescribing antidepressants.
    Shultz E; Malone DA
    Cleve Clin J Med; 2013 Oct; 80(10):625-31. PubMed ID: 24085807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sexual dysfunction during treatment of depression].
    Zieba A; Dudek D; Wróbel A
    Przegl Lek; 2000; 57(7-8):415-8. PubMed ID: 11109317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression.
    Pae CU; Lee C; Paik IH
    Med Hypotheses; 2007; 69(1):132-5. PubMed ID: 17196760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microarray analysis in drug discovery: an uplifting view of depression.
    Levy SE
    Sci STKE; 2003 Oct; 2003(206):pe46. PubMed ID: 14583588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
    Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
    Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
    Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
    Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Criticisms of drugs in early development for the treatment of depression: what can be improved?
    Wang SM; Han C; Pae CU
    Expert Opin Investig Drugs; 2015 Apr; 24(4):445-53. PubMed ID: 25529224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newer medications for complicated depression.
    Thase ME
    J Clin Psychiatry; 2009 Sep; 70(9):e33. PubMed ID: 19818239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment-resistant depression: critique of current approaches.
    Wijeratne C; Sachdev P
    Aust N Z J Psychiatry; 2008 Sep; 42(9):751-62. PubMed ID: 18696279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.